Mason Street Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-64,300
Closed -$782K 1538
2014
Q4
$782K Buy
+64,300
New +$782K 0.01% 1255